Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith D Goldberg

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Clinical Breast Cancer|January 18, 2016
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant ChemotherapyKomal Jhaveri, Eleonora Teplinsky, Deborah Silvera, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanomaNikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, et al.
Journal of Neurology|August 12, 2025
Multi-modal proton and sodium MRI for outcome prediction in mild traumatic brain injuryAnna M Chen, Teresa Gerhalter, Zhongyang Ma, et al.
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Neuro-Oncology|May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasMatthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
European Urology|April 7, 2026
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 TrialMinas P Economides, Peter H O'Donnell, Ajjai S Alva, et al.
Kidney International|June 18, 2004
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneitySongshan Jiang, Jordan Gitlin, Fang-Ming Deng, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Clinical Breast Cancer|January 18, 2016
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant ChemotherapyKomal Jhaveri, Eleonora Teplinsky, Deborah Silvera, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanomaNikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, et al.
Journal of Neurology|August 12, 2025
Multi-modal proton and sodium MRI for outcome prediction in mild traumatic brain injuryAnna M Chen, Teresa Gerhalter, Zhongyang Ma, et al.
Blood Advances|December 20, 2018
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasmsRaajit K Rampal, John O Mascarenhas, Heidi E Kosiorek, et al.
Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Neuro-Oncology|May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomasMatthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
European Urology|April 7, 2026
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 TrialMinas P Economides, Peter H O'Donnell, Ajjai S Alva, et al.
Kidney International|June 18, 2004
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneitySongshan Jiang, Jordan Gitlin, Fang-Ming Deng, et al.
Pageof 13